TipRanks
Advertisement
Advertisement

DE:BT3 Stock Latest News

Lineage Cell announces issuance of patent underlying AlloSCOPE 5D platform
The FlyLineage Cell announces issuance of patent underlying AlloSCOPE 5D platform
29d ago
LCTX
Lineage Cell Therapeutics management to meet with B. Riley
PremiumThe Fly
Lineage Cell Therapeutics management to meet with B. Riley
1M ago
LCTX
Lineage Maintained at Buy with Unchanged $3 Target as Cell Therapy Pipeline and DOSED SCI Trial Advance
PremiumRatings
Lineage Maintained at Buy with Unchanged $3 Target as Cell Therapy Pipeline and DOSED SCI Trial Advance
2M ago
LCTX
Lineage Cell Therapeutics Balances Progress and Risk
PremiumCompany Announcements
Lineage Cell Therapeutics Balances Progress and Risk
2M ago
LCTX
Lineage Maintained at Buy as Analyst Cites Clinical Momentum and Strategic Backing; $9 Price Target Reaffirmed
PremiumRatings
Lineage Maintained at Buy as Analyst Cites Clinical Momentum and Strategic Backing; $9 Price Target Reaffirmed
2M ago
LCTX
Lineage Cell Therapeutics reports Q2 EPS (3c), consensus (3c)
PremiumThe FlyLineage Cell Therapeutics reports Q2 EPS (3c), consensus (3c)
2M ago
LCTX
LCTX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
LCTX Upcoming Earnings Report: What to Expect?
2M ago
LCTX
Lineage Cell Therapeutics provides update on COR1 program
Premium
The Fly
Lineage Cell Therapeutics provides update on COR1 program
3M ago
LCTX
Lineage Cell Shareholders Reaffirm Governance and Executive Pay
PremiumCompany Announcements
Lineage Cell Shareholders Reaffirm Governance and Executive Pay
4M ago
8K
LCTX
Lineage Cell Therapeutics Highlights R&D Momentum Amid Losses
PremiumCompany Announcements
Lineage Cell Therapeutics Highlights R&D Momentum Amid Losses
5M ago
LCTX
Lineage Cell Therapeutics reports Q1 EPS (3c), consensus (2c)
PremiumThe Fly
Lineage Cell Therapeutics reports Q1 EPS (3c), consensus (2c)
5M ago
LCTX
Lineage Cell sees cash, equivalents funding operations into 2Q28
PremiumThe Fly
Lineage Cell sees cash, equivalents funding operations into 2Q28
5M ago
LCTX
LCTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsLCTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
LCTX
Lineage Cell announces 36-month results from Phase 1/2a study of RG6501
Premium
The Fly
Lineage Cell announces 36-month results from Phase 1/2a study of RG6501
5M ago
CHRO
LCTX
Lineage Cell Therapeutics initiated with a Buy at Canaccord
Premium
The Fly
Lineage Cell Therapeutics initiated with a Buy at Canaccord
5M ago
LCTX
Lineage Cell Therapeutics announces formation of Scientific Advisory Board
PremiumThe Fly
Lineage Cell Therapeutics announces formation of Scientific Advisory Board
6M ago
LCTX
Lineage Cell Therapeutics management to meet with Craig-Hallum
PremiumThe Fly
Lineage Cell Therapeutics management to meet with Craig-Hallum
6M ago
LCTX
Lineage Cell Therapeutics price target raised to $4 from $3 at B. Riley
PremiumThe Fly
Lineage Cell Therapeutics price target raised to $4 from $3 at B. Riley
7M ago
LCTX
Lineage Cell launches cell therapy program in corneal endothelial disease
PremiumThe Fly
Lineage Cell launches cell therapy program in corneal endothelial disease
7M ago
LCTX
Lineage Therap Expands ATM Equity Offering Capacity
PremiumCompany AnnouncementsLineage Therap Expands ATM Equity Offering Capacity
7M ago
8K
LCTX
Lineage Cell Therapeutics Extends Runway Amid R&D Surge
Premium
Company Announcements
Lineage Cell Therapeutics Extends Runway Amid R&D Surge
7M ago
LCTX
Regulatory Risks Loom for Lineage Cell Therapeutics as Legacy Pluripotent Cell Lines Face Potential Compliance Challenges
Premium
Company Announcements
Regulatory Risks Loom for Lineage Cell Therapeutics as Legacy Pluripotent Cell Lines Face Potential Compliance Challenges
7M ago
LCTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >